These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39074738)

  • 1. Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China.
    Chen H; Zhang H; Cheng J; Sun D; Wang Q; Wu C; Liu Y; Xia Y; Xu C; Zhang C
    Int J Infect Dis; 2024 Oct; 147():107196. PubMed ID: 39074738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of tuberculosis preventive therapy with INH-Rifapentine (3HP) for latent tuberculosis infection management in household tuberculosis contacts in India: A prospective study.
    Sharma N; Bakshi R; Basu S; Zode M; Arora R; Khanna A
    Trop Med Int Health; 2023 Dec; 28(12):890-900. PubMed ID: 37864386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis.
    Sagili KD; Muniyandi M; Shringarpure K; Singh K; Kirubakaran R; Rao R; Tonsing J; Sachdeva KS; Tharyan P
    Trop Med Int Health; 2022 Oct; 27(10):842-863. PubMed ID: 35927930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis.
    Kendall EA; Hussain H; Kunkel A; Kubiak RW; Trajman A; Menzies R; Drain PK
    BMC Med; 2021 Dec; 19(1):315. PubMed ID: 34903214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial.
    Bonnet M; Vasiliu A; Tchounga BK; Cuer B; Fielding K; Ssekyanzi B; Tchakounte Youngui B; Cohn J; Dodd PJ; Tiendrebeogo G; Tchendjou P; Simo L; Okello RF; Kuate Kuate A; Turyahabwe S; Atwine D; Graham SM; Casenghi M;
    Lancet Glob Health; 2023 Dec; 11(12):e1911-e1921. PubMed ID: 37918417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting.
    Kay AW; Sandoval M; Mtetwa G; Mkhabela M; Ndlovu B; Devezin T; Sikhondze W; Vambe D; Sibanda J; Dube GS; Stevens RH; Lukhele B; Mandalakas AM
    Clin Infect Dis; 2022 May; 74(9):1631-1638. PubMed ID: 34302733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
    Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
    BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong, China.
    Yuan Y; Jin J; Bi X; Geng H; Li S; Zhou C
    BMC Infect Dis; 2023 Jan; 23(1):38. PubMed ID: 36670356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis Preventive Treatment.
    Tayal A; Kabra SK
    Indian J Pediatr; 2024 Aug; 91(8):823-829. PubMed ID: 38095783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges.
    Mahajan P; Soundappan K; Singla N; Mehta K; Nuken A; Thekkur P; Nair D; Rattan S; Thakur C; Sachdeva KS; Kalottee B
    Trop Med Infect Dis; 2023 Dec; 9(1):. PubMed ID: 38251204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea.
    Lee J; Kim D; Hwang J; Kwon JW
    Int J Infect Dis; 2024 Apr; 141():106961. PubMed ID: 38340783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Tuberculosis Preventive Treatment Uptake and Completion Rates Using a Person-Centered Approach among Tuberculosis Household Contact in Yogyakarta.
    Felisia F; Triasih R; Nababan BWY; Sanjaya GY; Dewi SC; Rahayu ES; Unwanah L; du Cros P; Chan G
    Trop Med Infect Dis; 2023 Dec; 8(12):. PubMed ID: 38133452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
    Surey J; Stagg HR; Yates TA; Lipman M; White PJ; Charlett A; Muñoz L; Gosce L; Rangaka MX; Francis M; Hack V; Kunst H; Abubakar I
    BMC Infect Dis; 2021 Jan; 21(1):90. PubMed ID: 33478428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and Completion of Tuberculosis Preventive Treatment Using 12-Dose, Weekly Isoniazid-Rifapentine Regimen in Bangladesh: A Community-Based Implementation Study.
    Rahman MT; Hossain F; Banu RS; Islam MS; Alam S; Faisel AJ; Salim H; Cordon O; Suarez P; Hussain H; Roy T
    Trop Med Infect Dis; 2023 Dec; 9(1):. PubMed ID: 38276634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis.
    Zhou G; Luo S; He J; Chen N; Zhang Y; Cai S; Guo X; Chen H; Song C
    Clin Microbiol Infect; 2024 Feb; 30(2):189-196. PubMed ID: 37741621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
    Huang YW; Yang SF; Yeh YP; Tsao TC; Tsao SM
    Medicine (Baltimore); 2016 Aug; 95(34):e4126. PubMed ID: 27559940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of women-led community interventions in improving tuberculosis preventive treatment in children: results from a comparative, before-after study in Ethiopia.
    Jerene D; Assefa D; Tesfaye K; Bayu S; Seid S; Aberra F; Bedru A; Khan A; Creswell J
    BMJ Open; 2022 Jul; 12(7):e062298. PubMed ID: 35863840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.